Page last updated: 2024-12-08
phelorphan
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Description
phelorphan: enkephalinase inhibitor [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 187071 |
SCHEMBL ID | 9069169 |
MeSH ID | M0151928 |
Synonyms (13)
Synonym |
---|
phelorphan |
110871-16-4 |
(2s)-3-phenyl-2-[[(2s)-3-phenyl-2-[(2-sulfanylacetyl)amino]propanoyl]amino]propanoic acid |
l-phenylalanine, n-(n-(mercaptoacetyl)-l-phenylalanyl)- |
2-mercaptoacetyl-l-phenylalanyl-l-phenylalanine |
2-mercaptoacetyl-phenylalanylphenylalanine |
SCHEMBL9069169 |
DTXSID80911882 |
n-{1-hydroxy-2-[(1-hydroxy-2-sulfanylethylidene)amino]-3-phenylpropylidene}phenylalanine |
(2-mercaptoacetyl)-l-phenylalanyl-l-phenylalanine |
gtpl11655 |
deamino-norcysteinyl-l-phenylalanyl-l-phenylalanine |
AKOS040747267 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (5)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 5 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |